StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Sun Pharmaceutical Industries Limited
NSE:SUNPHARMA.NS
Sector
Location
Market Cap
USD 46.84 B
Share Price
USD 19.50
Avg Daily Volume
2,615,631
Change (1 day)
-0.06%
Change (1 year)
2.73%
Change (YTD)
-11.52%
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2025: USD 1.65 B
Sun Pharmaceutical Industries Limited Operating Cash Flow is USD 1.65 B for the year ending March 31, 2025, a 13.19% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2024 was USD 1.45 B, a 141.11% change year over year.
-
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2023 was USD 603.40 M, a -49.01% change year over year.
-
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2022 was USD 1.18 B, a 40.42% change year over year.
-
Sun Pharmaceutical Industries Limited Operating Cash Flow for the year ending March 31, 2021 was USD 842.69 M, a -3.12% change year over year.
Competitors
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
Johnson & Johnson
USD 156.28
JNJ
+0.49
0.32%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
McKesson Corporation
USD 727.23
MCK
+3.12
0.43%
Elevance Health Inc.
USD 346.36
ELV
-3.10
-0.89%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Cencora, Inc.
USD 300.16
COR
+2.13
0.71%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Lonza Group AG
USD 707.59
LONN.SW
+10.64
1.53%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 786.92
LLY
+9.26
1.19%
Johnson & Johnson
USD 156.28
JNJ
+0.49
0.32%
AbbVie Inc.
USD 190.62
ABBV
+0.85
0.45%
Roche Holding AG
USD 347.13
RO.SW
+4.68
1.37%
AstraZeneca PLC
USD 140.76
AZN.L
+0.34
0.24%
Merck & Co., Inc.
USD 83.71
MRK
+2.34
2.88%
Amgen Inc.
USD 296.52
AMGN
-0.48
-0.16%
Pfizer Inc.
USD 25.56
PFE
-0.06
-0.23%
Gilead Sciences, Inc.
USD 113.24
GILD
+2.18
1.96%
Sanofi
USD 97.65
SAN.PA
-0.05
-0.05%
Bristol-Myers Squibb Company
USD 47.66
BMY
+0.62
1.32%
McKesson Corporation
USD 727.23
MCK
+3.12
0.43%
Elevance Health Inc.
USD 346.36
ELV
-3.10
-0.89%
GSK plc
USD 19.36
GSK.L
+0.16
0.81%
Chugai Pharmaceutical Co., Ltd.
USD 46.51
4519.T
-0.57
-1.20%
Cencora, Inc.
USD 300.16
COR
+2.13
0.71%
Regeneron Pharmaceuticals, Inc.
USD 552.58
REGN
+4.83
0.88%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.96
600276.SS
+0.52
7.00%
Lonza Group AG
USD 707.59
LONN.SW
+10.64
1.53%
Takeda Pharmaceutical Company Limited
USD 30.27
4502.T
+0.31
1.03%